Now Playing:

Today, Boston Scientific said it will continue with plans to acquire rival medical device maker Guidant, despite Guidant's profit warning last week. Also, Guidant is in more trouble with the FDA - it sent a letter to the company today about problems at a Guidant facility. Marketplace's Helen Palmer explains.